DNA Origami Nanovaccine Demonstrates Full Protection Against SARS-CoV-2 in Mice
A study recently published in Communications Biology (Nature Portfolio) by Esra Oktay, Farhang Alem, Keziah Hernandez, Michael Girgis, Christopher Green, Divita Mathur, Igor L. Medintz, Aarthi Narayanan, and Rémí Veneziano introduces an innovative DNA origami–based nanovaccine platform targeting the receptor-binding domain (RBD) of SARS-CoV-2. Their findings highlight the potential of rationally engineered DNA nanoparticles to … Continue reading DNA Origami Nanovaccine Demonstrates Full Protection Against SARS-CoV-2 in Mice